BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 29896411)

  • 21. The SPID-GBA study: Sex distribution, Penetrance, Incidence, and Dementia in GBA-PD.
    Straniero L; Asselta R; Bonvegna S; Rimoldi V; Melistaccio G; Soldà G; Aureli M; Della Porta M; Lucca U; Di Fonzo A; Zecchinelli A; Pezzoli G; Cilia R; Duga S
    Neurol Genet; 2020 Dec; 6(6):e523. PubMed ID: 33209983
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Decreased delta-band event-related power in dementia with Lewy bodies with a mutation in the glucocerebrosidase gene.
    Rosenblum Y; Maidan I; Goldstein O; Gana-Weisz M; Orr-Urtreger A; Bregman N; Giladi N; Mirelman A; Shiner T
    Clin Neurophysiol; 2022 Nov; 143():14-20. PubMed ID: 36087397
    [TBL] [Abstract][Full Text] [Related]  

  • 23. α-Synuclein accumulation and GBA deficiency due to L444P GBA mutation contributes to MPTP-induced parkinsonism.
    Yun SP; Kim D; Kim S; Kim S; Karuppagounder SS; Kwon SH; Lee S; Kam TI; Lee S; Ham S; Park JH; Dawson VL; Dawson TM; Lee Y; Ko HS
    Mol Neurodegener; 2018 Jan; 13(1):1. PubMed ID: 29310663
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinical and pathological study on early diagnosis of Parkinson's disease and dementia with Lewy bodies].
    Orimo S
    Rinsho Shinkeigaku; 2008 Jan; 48(1):11-24. PubMed ID: 18386627
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Are dementia with Lewy bodies and Parkinson's disease dementia the same disease?
    Jellinger KA; Korczyn AD
    BMC Med; 2018 Mar; 16(1):34. PubMed ID: 29510692
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lewy body-related alpha-synucleinopathy in the aged human brain.
    Jellinger KA
    J Neural Transm (Vienna); 2004 Oct; 111(10-11):1219-35. PubMed ID: 15480835
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glucocerebrosidase and Parkinson Disease: Molecular, Clinical, and Therapeutic Implications.
    Balestrino R; Schapira AHV
    Neuroscientist; 2018 Oct; 24(5):540-559. PubMed ID: 29400127
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Striatal DAT and extrastriatal SERT binding in early-stage Parkinson's disease and dementia with Lewy bodies, compared with healthy controls: An
    Joling M; Vriend C; Raijmakers PGHM; van der Zande JJ; Lemstra AW; Berendse HW; Booij J; van den Heuvel OA
    Neuroimage Clin; 2019; 22():101755. PubMed ID: 30884365
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dementia with Lewy bodies.
    McKeith IG; Burn DJ; Ballard CG; Collerton D; Jaros E; Morris CM; McLaren A; Perry EK; Perry R; Piggott MA; O'Brien JT
    Semin Clin Neuropsychiatry; 2003 Jan; 8(1):46-57. PubMed ID: 12567332
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A critical reappraisal of current staging of Lewy-related pathology in human brain.
    Jellinger KA
    Acta Neuropathol; 2008 Jul; 116(1):1-16. PubMed ID: 18592254
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alpha-synuclein pathology in Parkinson's and Alzheimer's disease brain: incidence and topographic distribution--a pilot study.
    Jellinger KA
    Acta Neuropathol; 2003 Sep; 106(3):191-201. PubMed ID: 12845452
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A critical evaluation of current staging of alpha-synuclein pathology in Lewy body disorders.
    Jellinger KA
    Biochim Biophys Acta; 2009 Jul; 1792(7):730-40. PubMed ID: 18718530
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Cerebrospinal fluid and plasma biomarkers for dementia with lewy bodies].
    Kasuga K; Ikeuchi T
    Brain Nerve; 2012 May; 64(5):505-13. PubMed ID: 22570064
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Parkinson's and Lewy body dementia CSF biomarkers.
    Parnetti L; Paciotti S; Farotti L; Bellomo G; Sepe FN; Eusebi P
    Clin Chim Acta; 2019 Aug; 495():318-325. PubMed ID: 31051162
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Peripheral α-synuclein isoforms are potential biomarkers for diagnosis and prognosis of isolated REM sleep behavior disorder.
    Arnaldo L; Urbizu A; Serradell M; Gaig C; Anillo A; Gea M; Vilas D; Ispierto L; Muñoz-Lopetegi A; Mayà G; Pastor P; Álvarez R; Santamaria J; Iranzo A; Beyer K
    Parkinsonism Relat Disord; 2023 Oct; 115():105832. PubMed ID: 37678102
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Frontal and subcortical contribution to visual hallucinations in dementia with Lewy bodies and Parkinson's disease.
    Pezzoli S; Cagnin A; Antonini A; Venneri A
    Postgrad Med; 2019 Sep; 131(7):509-522. PubMed ID: 31422718
    [No Abstract]   [Full Text] [Related]  

  • 37. CSF Protein Level of Neurotransmitter Secretion, Synaptic Plasticity, and Autophagy in PD and DLB.
    Lerche S; Sjödin S; Brinkmalm A; Blennow K; Wurster I; Roeben B; Zimmermann M; Hauser AK; Liepelt-Scarfone I; Waniek K; Lachmann I; Gasser T; Zetterberg H; Brockmann K
    Mov Disord; 2021 Nov; 36(11):2595-2604. PubMed ID: 34180557
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies.
    Baba M; Nakajo S; Tu PH; Tomita T; Nakaya K; Lee VM; Trojanowski JQ; Iwatsubo T
    Am J Pathol; 1998 Apr; 152(4):879-84. PubMed ID: 9546347
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [GBA mutations and Parkinson's disease].
    Wang DX; Xie JX; Song N
    Sheng Li Xue Bao; 2018 Jun; 70(3):294-300. PubMed ID: 29926071
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of α-synuclein is regulated in a neuronal cell type-dependent manner.
    Taguchi K; Watanabe Y; Tsujimura A; Tanaka M
    Anat Sci Int; 2019 Jan; 94(1):11-22. PubMed ID: 30362073
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.